vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与PREFORMED LINE PRODUCTS CO（PLPC）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是PREFORMED LINE PRODUCTS CO的1.9倍（$321.1M vs $173.1M），PREFORMED LINE PRODUCTS CO净利率更高（4.9% vs -18.2%，领先23.1%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 3.6%），PREFORMED LINE PRODUCTS CO自由现金流更多（$11.8M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
MDGL vs PLPC — 直观对比
营收规模更大
MDGL
是对方的1.9倍
$173.1M
营收增速更快
MDGL
高出207.2%
3.6%
净利率更高
PLPC
高出23.1%
-18.2%
自由现金流更多
PLPC
多$145.6M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $173.1M |
| 净利润 | $-58.6M | $8.4M |
| 毛利率 | — | 29.8% |
| 营业利润率 | -18.6% | 6.8% |
| 净利率 | -18.2% | 4.9% |
| 营收同比 | 210.8% | 3.6% |
| 净利润同比 | 1.4% | -19.3% |
| 每股收益（稀释后） | $-2.55 | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLPLPC
| Q4 25 | $321.1M | $173.1M | ||
| Q3 25 | $287.3M | $178.1M | ||
| Q2 25 | $212.8M | $169.6M | ||
| Q1 25 | $137.3M | $148.5M | ||
| Q4 24 | $103.3M | $167.1M | ||
| Q3 24 | $62.2M | $147.0M | ||
| Q2 24 | — | $138.7M | ||
| Q1 24 | $0 | $140.9M |
净利润MDGLPLPC
| Q4 25 | $-58.6M | $8.4M | ||
| Q3 25 | $-114.2M | $2.6M | ||
| Q2 25 | $-42.3M | $12.7M | ||
| Q1 25 | $-73.2M | $11.5M | ||
| Q4 24 | $-59.4M | $10.5M | ||
| Q3 24 | $-107.0M | $7.7M | ||
| Q2 24 | — | $9.4M | ||
| Q1 24 | $-147.5M | $9.6M |
毛利率MDGLPLPC
| Q4 25 | — | 29.8% | ||
| Q3 25 | — | 29.7% | ||
| Q2 25 | — | 32.7% | ||
| Q1 25 | 96.7% | 32.8% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | — | 31.1% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 31.3% |
营业利润率MDGLPLPC
| Q4 25 | -18.6% | 6.8% | ||
| Q3 25 | -39.7% | 7.4% | ||
| Q2 25 | -22.2% | 10.1% | ||
| Q1 25 | -57.8% | 8.8% | ||
| Q4 24 | -64.8% | 10.5% | ||
| Q3 24 | -187.1% | 7.1% | ||
| Q2 24 | — | 8.1% | ||
| Q1 24 | — | 8.2% |
净利率MDGLPLPC
| Q4 25 | -18.2% | 4.9% | ||
| Q3 25 | -39.8% | 1.5% | ||
| Q2 25 | -19.9% | 7.5% | ||
| Q1 25 | -53.4% | 7.8% | ||
| Q4 24 | -57.5% | 6.3% | ||
| Q3 24 | -172.0% | 5.2% | ||
| Q2 24 | — | 6.8% | ||
| Q1 24 | — | 6.8% |
每股收益（稀释后）MDGLPLPC
| Q4 25 | $-2.55 | $1.72 | ||
| Q3 25 | $-5.08 | $0.53 | ||
| Q2 25 | $-1.90 | $2.56 | ||
| Q1 25 | $-3.32 | $2.33 | ||
| Q4 24 | $-2.50 | $2.13 | ||
| Q3 24 | $-4.92 | $1.54 | ||
| Q2 24 | — | $1.89 | ||
| Q1 24 | $-7.38 | $1.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | — |
| 总债务越低越好 | $339.9M | $38.3M |
| 股东权益账面价值 | $602.7M | $475.5M |
| 总资产 | $1.3B | $653.6M |
| 负债/权益比越低杠杆越低 | 0.56× | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资MDGLPLPC
| Q4 25 | $198.7M | — | ||
| Q3 25 | $295.7M | — | ||
| Q2 25 | $186.2M | — | ||
| Q1 25 | $183.6M | — | ||
| Q4 24 | $100.0M | — | ||
| Q3 24 | $232.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $622.5M | — |
总债务MDGLPLPC
| Q4 25 | $339.9M | $38.3M | ||
| Q3 25 | $339.8M | $36.0M | ||
| Q2 25 | $118.4M | $31.8M | ||
| Q1 25 | $118.0M | $29.1M | ||
| Q4 24 | $117.6M | $20.8M | ||
| Q3 24 | $117.1M | $27.2M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | $116.1M | $55.0M |
股东权益MDGLPLPC
| Q4 25 | $602.7M | $475.5M | ||
| Q3 25 | $625.7M | $466.3M | ||
| Q2 25 | $696.0M | $460.7M | ||
| Q1 25 | $710.6M | $435.8M | ||
| Q4 24 | $754.4M | $422.3M | ||
| Q3 24 | $777.2M | $429.0M | ||
| Q2 24 | — | $416.2M | ||
| Q1 24 | $850.8M | $413.4M |
总资产MDGLPLPC
| Q4 25 | $1.3B | $653.6M | ||
| Q3 25 | $1.4B | $644.6M | ||
| Q2 25 | $1.0B | $631.5M | ||
| Q1 25 | $996.6M | $592.5M | ||
| Q4 24 | $1.0B | $573.9M | ||
| Q3 24 | $1.1B | $592.0M | ||
| Q2 24 | — | $572.6M | ||
| Q1 24 | $1.1B | $586.1M |
负债/权益比MDGLPLPC
| Q4 25 | 0.56× | 0.08× | ||
| Q3 25 | 0.54× | 0.08× | ||
| Q2 25 | 0.17× | 0.07× | ||
| Q1 25 | 0.17× | 0.07× | ||
| Q4 24 | 0.16× | 0.05× | ||
| Q3 24 | 0.15× | 0.06× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | 0.14× | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $21.9M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $11.8M |
| 自由现金流率自由现金流/营收 | -41.7% | 6.8% |
| 资本支出强度资本支出/营收 | 0.1% | 5.9% |
| 现金转化率经营现金流/净利润 | — | 2.60× |
| 过去12个月自由现金流最近4个季度 | — | $33.3M |
8季度趋势，按日历期对齐
经营现金流MDGLPLPC
| Q4 25 | $-133.5M | $21.9M | ||
| Q3 25 | $79.8M | $18.9M | ||
| Q2 25 | $-47.1M | $26.9M | ||
| Q1 25 | $-88.9M | $5.7M | ||
| Q4 24 | $-104.5M | $24.1M | ||
| Q3 24 | $-67.0M | $9.4M | ||
| Q2 24 | — | $28.3M | ||
| Q1 24 | $-149.2M | $5.8M |
自由现金流MDGLPLPC
| Q4 25 | $-133.8M | $11.8M | ||
| Q3 25 | $79.0M | $8.3M | ||
| Q2 25 | — | $18.6M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | $-104.7M | $20.6M | ||
| Q3 24 | $-67.8M | $5.8M | ||
| Q2 24 | — | $24.6M | ||
| Q1 24 | $-149.5M | $1.8M |
自由现金流率MDGLPLPC
| Q4 25 | -41.7% | 6.8% | ||
| Q3 25 | 27.5% | 4.7% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | -3.6% | ||
| Q4 24 | -101.3% | 12.3% | ||
| Q3 24 | -109.0% | 3.9% | ||
| Q2 24 | — | 17.7% | ||
| Q1 24 | — | 1.3% |
资本支出强度MDGLPLPC
| Q4 25 | 0.1% | 5.9% | ||
| Q3 25 | 0.3% | 6.0% | ||
| Q2 25 | 0.0% | 4.9% | ||
| Q1 25 | 0.0% | 7.4% | ||
| Q4 24 | 0.2% | 2.1% | ||
| Q3 24 | 1.3% | 2.4% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.8% |
现金转化率MDGLPLPC
| Q4 25 | — | 2.60× | ||
| Q3 25 | — | 7.21× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 3.02× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
PLPC
暂无分部数据
